Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD
Clinical Kidney Journal · 02.11.2026 · 19 (11)
DOI: 10.1093/ckj/sfag386 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 29.10.2026. Verfasst von Qi Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Wuhan Fourth Hospital, Wuhan Clinical Research Center for Metabolic Chronic Kidney Disease, Wuhan, Hubei, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Municipal Medical Institutions of Wuhan, Hubei Province Nephrology Scientific Innovation Project, National Health Commission Capacity Building and Continuing Education Center.
Abstract (Originalsprache)
Background
Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended as first-line therapy for patients with chronic kidney disease (CKD). However, the prevalence and prognostic significance of a large early estimated glomerular filtration rate (eGFR) dip after SGLT2i initiation in real-world CKD populations remain unclear.
Methods
We conducted a multicenter retrospective cohort study using the China Renal Data System. Adult hospitalized patients with eGFR ≥20 ml/min/1.73 m2 who newly initiated SGLT2i were included. Exposure was defined as an eGFR decline ≥20% within 14–30 days after treatment initiation. Follow-up began 30 days after initiation. The outcomes were all-cause mortality within 45 days and all-cause mortality from 46 days to 1 year. Inverse probability of treatment weighting-weighted landmark Cox model was performed to evaluate these associations.
Results
Among 1258 eligible patients (mean age 64.4 years; 69.3% male), 22.5% experienced an early eGFR dip ≥20%. Higher incidence rates were observed in older patients, those with heart failure, diuretic use, and CKD stages 2–4. Compared with an eGFR dip <20%, an eGFR dip ≥20% was associated with an increased risk of all-cause mortality within 45 days (adjusted hazard ratio [aHR], 8.08; 95% confidence interval [CI], 3.41–19.13). However, no significant association was observed between an eGFR dip ≥20% and all-cause mortality from 46 days to 1 year (aHR, 0.91; 95% CI, 0.48–1.74).
Conclusions
A substantial eGFR decline after SGLT2i initiation was not uncommon and was associated with increased short-term all-cause mortality, highlighting the importance of close kidney function monitoring and individualized clinical assessment of treatment continuation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Wuhan Fourth Hospital, Wuhan Clinical Research Center for Metabolic Chronic Kidney Disease, Wuhan, Hubei, China.
- School of Medicine, Jianghan University, Wuhan, Hubei, China.
- Division of Nephrology, National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Qi Gao, Honglan Wei
Förderung
- Municipal Medical Institutions of Wuhan
- Hubei Province Nephrology Scientific Innovation Project
- National Health Commission Capacity Building and Continuing Education Center
Zitieren
APA
Gao, Q., Ma, Z., Ren, W., Yu, Y., Wu, L., Zhang, Z., Wu, Z., Zhou, S., Su, L., Li, Y., Luo, F., Lin, Y., Dong, J., & Wei, H. (2026). Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD. Clinical Kidney Journal, 19(11). https://doi.org/10.1093/ckj/sfag386
Vancouver
Gao Q, Ma Z, Ren W, Yu Y, Wu L, Zhang Z, et al. Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD. Clinical Kidney Journal. 2026;19(11). doi:10.1093/ckj/sfag386
BibTeX
@article{Gao2026,
author = {Gao, Qi and Ma, Zhou and Ren, Weirong and Yu, Yaping and Wu, Lunlun and Zhang, Zhiqin and Wu, Zhongcai and Zhou, Shiyu and Su, Licong and Li, Yanqin and Luo, Fan and Lin, Yuxin and Dong, Junwu and Wei, Honglan},
title = {Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD},
journal = {Clinical Kidney Journal},
year = {2026},
volume = {19},
number = {11},
doi = {10.1093/ckj/sfag386}
}
EUVIMED